- Report
- August 2025
- 188 Pages
Global
From €3496EUR$3,939USD£3,009GBP
- Report
- April 2025
- 150 Pages
Global
From €3417EUR$3,850USD£2,941GBP
€4305EUR$4,850USD£3,705GBP
- Report
- February 2025
- 200 Pages
Global
From €3985EUR$4,490USD£3,430GBP
Biapenem is a type of antibiotic used to treat a variety of bacterial infections. It belongs to the carbapenem class of antibiotics, which are broad-spectrum antibiotics used to treat serious infections caused by Gram-negative bacteria. Biapenem is effective against a wide range of bacteria, including those that are resistant to other antibiotics. It is typically used to treat infections of the urinary tract, skin, and respiratory tract.
Biapenem is generally well-tolerated, with few side effects. It is usually administered intravenously, although some formulations are available for oral administration. It is often used in combination with other antibiotics to increase the effectiveness of treatment.
Biapenem is used in a variety of clinical settings, including hospitals, long-term care facilities, and outpatient clinics. It is also used in the treatment of infections in immunocompromised patients, such as those with HIV/AIDS or cancer.
Some companies in the biapenem market include Merck, Pfizer, AstraZeneca, and GlaxoSmithKline. Show Less Read more